http://purl.uniprot.org/citations/15312879 | http://www.w3.org/1999/02/22-rdf-syntax-ns#type | http://purl.uniprot.org/core/Journal_Citation |
http://purl.uniprot.org/citations/15312879 | http://www.w3.org/2000/01/rdf-schema#comment | "ObjectivesWe examined the effects of early treatment with a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor pravastatin on the progression of glucose intolerance and cardiovascular remodeling in a model of spontaneously developing type II diabetes mellitus (DM), the Otsuka Long-Evans Tokushima Fatty (OLETF) rats.BackgroundClinical trials showed that pravastatin prevented new-onset DM in hypercholesterolemic patients, and that it was effective in prevention of cardiovascular events in diabetics.MethodsThe OLETF rats were treated with pravastatin (100 mg/kg/day) from 5 weeks of age and compared with age-matched untreated OLETF rats and normal Long-Evans Tokushima Otsuka (LETO) rats on serial oral glucose tolerance tests (OGTT) and Doppler echocardiography and on histopathological/biochemical analyses of the heart at 30 weeks.ResultsThe OGTT revealed that 40% and 89% of untreated OLETF rats were diabetic at 20 and 30 weeks, respectively, but 0% and only 30%, respectively, were diabetic in the treated OLETF. Left ventricular diastolic function was found impaired from 20 weeks in untreated OLETF but remained normal in the treated-OLETF. The wall-to-lumen ratio and perivascular fibrosis of coronary arteries were increased in untreated-OLETF but were limited in the treated-OLETF at 30 weeks. Moreover, cardiac expressions of a fibrogenic growth factor, transforming growth factor-beta1 (TGF-beta1), and a proinflammatory chemokine, monocyte chemoattractant protein-1 (MCP-1), were increased in untreated-OLETF. However, in the treated-OLETF, overexpressions of TGF-beta1 and MCP-1 were attenuated, which was associated with overexpression of endothelial nitric oxide synthase (eNOS) (2.5-fold of control LETO).ConclusionsEarly pravastatin treatment prevented cardiovascular remodeling in the spontaneous DM model by retarding the progression of glucose intolerance, overexpressing cardiac eNOS, and inhibiting overexpressions of fibrogenic/proinflammatory cytokines."xsd:string |
http://purl.uniprot.org/citations/15312879 | http://purl.org/dc/terms/identifier | "doi:10.1016/j.jacc.2004.04.050"xsd:string |
http://purl.uniprot.org/citations/15312879 | http://purl.uniprot.org/core/author | "Chen Y."xsd:string |
http://purl.uniprot.org/citations/15312879 | http://purl.uniprot.org/core/author | "Yu Y."xsd:string |
http://purl.uniprot.org/citations/15312879 | http://purl.uniprot.org/core/author | "Takeuchi H."xsd:string |
http://purl.uniprot.org/citations/15312879 | http://purl.uniprot.org/core/author | "Sato C."xsd:string |
http://purl.uniprot.org/citations/15312879 | http://purl.uniprot.org/core/author | "Kohno M."xsd:string |
http://purl.uniprot.org/citations/15312879 | http://purl.uniprot.org/core/author | "Ohmori K."xsd:string |
http://purl.uniprot.org/citations/15312879 | http://purl.uniprot.org/core/author | "Shinomiya K."xsd:string |
http://purl.uniprot.org/citations/15312879 | http://purl.uniprot.org/core/author | "Kiyomoto H."xsd:string |
http://purl.uniprot.org/citations/15312879 | http://purl.uniprot.org/core/author | "Mizushige K."xsd:string |
http://purl.uniprot.org/citations/15312879 | http://purl.uniprot.org/core/date | "2004"xsd:gYear |
http://purl.uniprot.org/citations/15312879 | http://purl.uniprot.org/core/name | "J Am Coll Cardiol"xsd:string |
http://purl.uniprot.org/citations/15312879 | http://purl.uniprot.org/core/pages | "904-913"xsd:string |
http://purl.uniprot.org/citations/15312879 | http://purl.uniprot.org/core/title | "Effects of pravastatin on progression of glucose intolerance and cardiovascular remodeling in a type II diabetes model."xsd:string |
http://purl.uniprot.org/citations/15312879 | http://purl.uniprot.org/core/volume | "44"xsd:string |
http://purl.uniprot.org/citations/15312879 | http://www.w3.org/2004/02/skos/core#exactMatch | http://purl.uniprot.org/pubmed/15312879 |
http://purl.uniprot.org/citations/15312879 | http://xmlns.com/foaf/0.1/primaryTopicOf | https://pubmed.ncbi.nlm.nih.gov/15312879 |
http://purl.uniprot.org/uniprot/#_A0A8I6AUL2-mappedCitation-15312879 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/15312879 |
http://purl.uniprot.org/uniprot/#_A0A8I6AV02-mappedCitation-15312879 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/15312879 |
http://purl.uniprot.org/uniprot/#_A0A8L2QCN8-mappedCitation-15312879 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/15312879 |
http://purl.uniprot.org/uniprot/#_A0A8I6A6Z9-mappedCitation-15312879 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/15312879 |
http://purl.uniprot.org/uniprot/#_P51639-mappedCitation-15312879 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/15312879 |
http://purl.uniprot.org/uniprot/A0A8I6AUL2 | http://purl.uniprot.org/core/mappedCitation | http://purl.uniprot.org/citations/15312879 |